Bavarian Nordic A/S - Major Shareholder Announcement


Kvistgård, Denmark, February 2, 2010 - Bavarian Nordic A/S (OMX: BAVA) announces
in pursuance of the Danish Securities Trading Act's section 29, that the company
has received information that A.J. Aamund A/S due to dilution after completion
of the rights issue has decreased its holding of shares in Bavarian Nordic A/S.

A.J. Aamund A/S has subscribed for 219.200 new shares in the rights issue and
subsequently holds a total of 1,556,148 shares, corresponding to approximately
13.1 % of the total share capital of Bavarian Nordic A/S.



Contact
Anders Hedegaard, President & CEO. Phone +45 23 20 30 64

Forward-looking statements
This announcement includes "forward-looking statements" that involve risks,
uncertainties and other factors, many of which are outside of our control that
could cause actual results to differ materially from the results discussed in
the forward-looking statements. Forward-looking statements include statements
concerning our plans, objectives, goals, future events, performance and/or other
information that is not historical information. We undertake no obligation to
publicly update or revise forward-looking statements to reflect subsequent
events or circumstances after the date made, except as required by law.

About Bavarian Nordic
Bavarian Nordic A/S is a leading industrial biotechnology company developing and
producing novel vaccines for the treatment and prevention of life-threatening
diseases with a large unmet medical need. The company's pipeline is focused in
the three areas; biodefence, cancer and infectious diseases, and includes seven
development programmes. Two programmes are under preparation for Phase III:
IMVAMUNE®, a third-generation smallpox vaccine is being developed under a
contract with the US government, and PROSTVAC(TM), a therapeutic vaccine for
advanced prostate cancer is being developed under a collaboration agreement with
the National Cancer Institute.

Bavarian Nordic is listed on NASDAQ OMX Copenhagen under the symbol BAVA.

For more information please visit www.bavarian-nordic.com
<http://www.bavarian-nordic.com/>




[HUG#1379903]


Attachments

2010-13-uk.pdf